Prevalence of nontuberculous mycobacteria in COPD patients with exacerbations

Journal of Infection

Volumn 66, Issue 6, 2013, Pages 542-545

  Hoefsloot, Wouter ^a   Van Ingen, Jakko ^a   Magis Escurra, Cecile ^a   Reijers, Monique H ^a   Van Soolingen, Dick ^a   Dekhuijzen, Richard P N ^b   Boeree, Martin J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHIMAERA; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM NONCHROMOGENICUM; MYCOBACTERIUM SIMIAE; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; SPUTUM CULTURE; THORAX RADIOGRAPHY;

FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84876876717     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.12.011     Document Type: Letter

References (9)

1. Barberan J., Sanz F., Hernandez J.L., Merlos S., Malmierca E., Garcia-Perez F.J., et al. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage. The Journal of Infection 2012, 65(5):447-452.
2. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine 2007, 175(4):367-416.
3. Marras T.K., Chedore P., Ying A.M., Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007, 62(8):661-666.
4. van Ingen J., Bendien S.A., de Lange W.C., Hoefsloot W., Dekhuijzen P.N., Boeree M.J., et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009, 64(6):502-506.
5. Springer B., Stockman L., Teschner K., Roberts G.D., Bottger E.C. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. Journal of Clinical Microbiology 1996, 34(2):296-303.
6. Ko F.W., Ip M., Chan P.K., Fok J.P., Chan M.C., Ngai J.C., et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007, 131(1):44-52.
7. Fritscher L.G., Marras T.K., Bradi A.C., Fritscher C.C., Balter M.S., Chapman K.R. Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest 2011, 139(1):23-27.
8. Martinez-Garcia M.A., Soler-Cataluna J.J., Donat Sanz Y., Catalan Serra P., Agramunt Lerma M., Ballestin Vicente J., et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011, 140(5):1130-1137.
9. Andrejak C., Nielsen R., Thomsen V.O., Duhaut P., Sorensen H.T., Thomsen R.W. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 2012.